At its height, NAIAS in Detroit was truly an international show, where anyone involved in the auto industry was expected to ...

J&J has reported positive topline outcomes from the MARIPOSA trial of RYBREVANT and LAZCLUZE combo for NSCLC treatment.

Risk for venous thromboembolism during pregnancy increased significantly from 2009 to 2019, with an average annual percent ...

Senior guard Myles Stute has been diagnosed with a left lower leg deep vein thrombosis (blood clot) the team announced on Tuesday night. He will be out indefinitely.

Medical devices behemoth Stryker agreed to buy Inari Medical for $4.9 billion late Monday. Inari stock catapulted on the news ...

After professing a hearty appetite for tuck-in M&A last year and signing a string of smaller deals, Stryker is now opening ...

Stryker acquires Inari Medical in a $4.9 billion deal, enhancing its vascular portfolio with innovative VTE treatments and a ...

Inari Medical Inc. (NARI), a medical device company, has agreed to be acquired by Stryker (SYK) for $80 per share in cash, equating ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...

Stryker announced a definitive agreement to acquire Inari Medical, Inc. for approximately $4.9 billion. Inari was founded in 201 ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...